The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...
Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback